So these little pills, in combination with radiation and immunotherapy, are supposed to cure me. I take them on an empty stomach one hour before radiation; thirty minutes after taking an anti-nausea pill. The treatment is a triple threat - chemo, radio and immuno. We found out this morning that I was accepted into a clinical trial for Nivolumab, the drug that has revolutionized melanoma treatment.
The Stage II clinical trial is arranged by Bristol Mayers Squibb. Lab Corp Ctr for Molecular Biology confirmed the results that the doctors in Oslo had gotten; that I have the MGMT mutation that should make my body more receptive to the Nivo. Of the 15 patients in Norway who are participating in this trial, I am only the 4th with the MGMT mutation.
No comments:
Post a Comment